May 8, 2020 / 12:27 PM / 18 days ago

BRIEF-Spero Therapeutics Announces First Quarter 2020 Operating Results And Provides Business Update

May 8 (Reuters) - Spero Therapeutics Inc:

* SPERO THERAPEUTICS ANNOUNCES FIRST QUARTER 2020 OPERATING RESULTS AND PROVIDES BUSINESS UPDATE

* Q1 REVENUE ESTIMATE $3.4 MILLION — REFINITIV IBES DATA

* AS OF MARCH 31, 2020, COMPANY HAD CASH AND CASH EQUIVALENTS OF $88.8 MILLION

* SPERO THERAPEUTICS - BELIEVES EXISTING CASH, CASH EQUIVALENTS, SUFFICIENT TO FUND OPERATING EXPENSES, CAPEX REQUIREMENTS INTO Q1 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below